TVTX Operating Cash Flow Growth
Travere Therapeutics Inc · Operating Cash Flow Growth
TVTX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported180.30%period ending
TVTX TTM Cash from Operations YoY % (-21127.78% → 180.30%)
Year-over-year change
High-resolution chart · PNG
TVTX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 180.3028% | |
| 124.6552% | |
| 115.9107% | |
| 78.4688% | |
| 60.036% | |
| 49.4623% | |
| 15.1939% | |
| -3.0433% | |
| -18.1029% | |
| -49.8949% | |
| -50.3138% | |
| -66.6507% | |
| -181.3193% | |
| -386.0168% | |
| -1,159.4037% | |
| -8,781.1204% | |
| -220.658% | |
| -8.9262% | |
| 65.3932% | |
| 94.6501% | |
| 49.9954% | |
| 40.096% | |
| 26.5761% | |
| 41.7582% | |
| -15.2045% | |
| -117.7269% | |
| -133.2479% | |
| -157.5044% | |
| -270.3281% | |
| -574.3359% | |
| -437.1336% | |
| -1,589.0897% | |
| -2,221.7028% | |
| -465.8385% | |
| 563.8471% | |
| -42.9335% | |
| 185.9397% | |
| -125.0589% | |
| -188.0866% | |
| 136.8761% | |
| 97.0993% | |
| 107.4058% | |
| 98.7917% | |
| 84.189% | |
| 25.0462% | |
| -90.1167% | |
| -160.6704% | |
| 98.3649% | |
| 98.8317% | |
| 99.1678% | |
| 99.3574% | |
| -582,625.5224% | |
| -8,070,579,985.2941% | |
| -5,595,487,328.5714% | |
| -423,061,760.5873% | |
| -65,353.4722% | |
| 99.1102% | |
| 98.7156% | |
| -113.8841% | |
| -410.3448% | |
| -21,127.7778% |